Evidence map›Paper›PMID 21934646›Full record

ArticleMolecules (Basel, Switzerland)2011

Design and synthesis of new N-(5-trifluoromethyl)-1H-1,2,4-triazol-3-yl benzenesulfonamides as possible antimalarial prototypes.

Nubia Boechat, Luiz C S Pinheiro, Osvaldo A Santos-Filho, Isabor C Silva

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Steric Effects ofMolecules (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Pharmaceutical and medicinal significance of sulfur (SEuropean journal of medicinal chemistry · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nubia BoechatDepartamento de Sintese Organica, Instituto de Tecnologia em Farmacos, Fundacao Oswaldo Cruz, Manguinhos, CEP 21041-250, Rio de Janeiro, RJ, Brazil. boechat@far.fiocruz.br
Luiz C S Pinheiro
Osvaldo A Santos-Filho
Isabor C Silva

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A rational approach was used to synthesize a new set of 15 1H-1,2,4-triazol-3-yl benzenesulfonamide derivatives with the aim of developing new antimalarial lead compounds. These derivatives were prepared in yields between 50% and 62%, and their structures were elucidated using IR, ¹H-, ¹³C-, ¹⁹F-NMR, MS and elemental analysis. A docking study based on sulfonamides previously used against malaria identified trifluoromethyl-substituted derivatives to be the best lead compounds for new antimalarial drug development.

Indexed as

Amino Acid SequenceAntimalarialsBenzenesulfonamidesCatalytic DomainComputer SimulationConserved SequenceCyclizationDihydropteroate SynthaseDrug DesignFluorine CompoundsHydrogen BondingMagnetic Resonance SpectroscopyModels, MolecularMolecular Sequence DataMolecular StructurePlasmodium falciparumAntimalarialsBenzenesulfonamidesDihydropteroate SynthaseFluorine CompoundsSulfadiazineSulfadoxineSulfaleneSulfonamidesTriazoles

Identifiers

PMID21934646
PMCPMC6264137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.